BC Cancer Foundation's Discovery Luncheon
Wednesday, November 15, 2017


BC’s Southern Interior is one step closer to acquiring its first PET/CT scanner, thanks to a record-breaking amount raised at the November 15th Discovery Luncheon – Kelowna. Read the full release.

The event, in its seventh year, raised $150,000 to support the BC Cancer Foundation’s campaign to acquire a PET/CT scanner for the BC Cancer Sindi Ahluwalia Hawkins Centre for the Southern Interior.

The BC Cancer Foundation is now halfway to raising the $5-million needed to purchase the scanner, the most advanced diagnostic tool available today. PET/CT is vital in helping doctors diagnose cancer and create treatment plans for patients. There are currently only two publicly funded PET/CT scanners in B.C., both located at the BC Cancer Vancouver Centre.

Currently, more than 800 patients from the Southern Interior have to travel to Vancouver each year for a PET/CT scan they're counting on to save their lives. Many more are too unwell or don't have the support network to make the trip. With your help, PET/CT technology can provide more people with the most effective cancer care possible, without having to leave the region.

Past Discovery Luncheons have supported BC Cancer Agency researchers in making huge strides:

  • Expanded brachytherapy treatment program for women with gynaecological cancers.
  • HDR brachytherapy “boost” (implanted radiation in addition to standard external beam radiation) has become standard treatment for patients with high-tier intermediate and high-risk prostate cancer. It is now possible to perform three HDR procedures in a standard operating day, an achievement seen as impossible just a short time ago;
  • A pilot program is underway to determine the proportion of patients eligible for breast seed brachytherapy, improve the technique, adapt it for different breast sizes and tumour locations and incorporate new 3D ultrasound technology;
  • The PREDICT (Personal REsponse Determinants in Cancer Therapy) is now more than half-way to its goal of 20,000 participants, which will enable large-scale cancer and genomic research across many tumour types;
  • More than 20 clinical trials are currently underway including breast, prostate, lung, bladder and lymphoid cancer;
  • The Personalized Onco-Genomics (POG) Program is currently expanding to 2,000 patients. This added scope will provide researchers with valuable outcome data that will enable genomics to be integrated into standard cancer care.


For more information about the Kelowna Discovery Luncheon, please contact Chantelle Funk at chantelle.funk@bccancer.bc.ca or call 250.979.6652. Read more about the 2017 Discovery Luncheon.










BC Cancer Foundation Discover Luncheon Friend